Mouwasat Medical Services Company (4002.SR) — Cash flow
Operating, investing, and financing cash flow for Mouwasat Medical Services Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 822↑22.8% | 670↓2.7% | 688↑8.8% | 633↑0.1% | 632 | |
| Depreciation & Amortization | 244↑2.7% | 238↑6.5% | 223↑18.5% | 189↑19.7% | 157 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | 97↓66.1% | 286↑233.0% | -215↓71.9% | -125↓71.4% | -73 | |
| Accounts Receivable | 29↓80.7% | 150↑164.7% | -232↑11.0% | -261↓143.8% | -107 | |
| Inventory | -18↑48.0% | -35↓660.9% | 6↑137.7% | -16↓1159.0% | -1 | |
| Accounts Payable | 59↓3.9% | 61↑168.7% | 23↓16.5% | 27↑30.3% | 21 | |
| Other Working Capital | 27↓78.4% | 126↑1187.3% | -12↓109.3% | 125↑767.4% | 14 | |
| Other Non-Cash Items | 38↓40.7% | 63↓45.7% | 117↑959.1% | 11↑132.4% | -34 | |
| Net Cash from Operating Activities | 1,201↓4.4% | 1,256↑54.4% | 814↑15.1% | 707↑3.6% | 683 | |
| Operating Cash Flow | 1,201↓4.4% | 1,256↑54.4% | 814↑15.1% | 707↑3.6% | 683 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -791↓84.4% | -429↓49.7% | -287↑4.1% | -299↑9.6% | -330 | |
| Capital Expenditure | -773↓77.6% | -436↓52.0% | -287↑4.1% | -299↑9.6% | -330 | |
| Acquisitions | 7↑211.4% | 2 | 0.00↑100.0% | -101↓1947.1% | 5 | |
| Purchases of Investments | 0.00 | 0.00 | 0.00↑100.0% | -11↑35.3% | -17 | |
| Sales & Maturities of Investments | 85↑265.1% | 23 | 0.00↓100.0% | 101↑1947.1% | -5 | |
| Other Investing Activities | 0.07↑100.1% | -64↑65.9% | -188↓205.8% | -62↑37.5% | -98 | |
| Net Cash from Investing Activities | -699↓49.5% | -468↑1.5% | -475↓27.9% | -371↑16.7% | -446 | |
| Financing Activities | ||||||
| Net Debt Issuance | 210↑857.0% | -28↑71.3% | -96↓245.7% | 66↑30.2% | 51 | |
| Long-Term Net Debt Issuance | 210↑857.0% | -28↑71.3% | -96↓245.7% | 66↑30.2% | 51 | |
| Short-Term Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -600↓71.4% | -350↓16.7% | -300↓9.1% | -275↓10.0% | -250 | |
| Common Dividends Paid | -600↓71.4% | -350↓16.7% | -300↓9.1% | -275↓10.0% | -250 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -41↓21.3% | -34↑10.2% | -38↑2.8% | -39↑6.3% | -41 | |
| Net Cash from Financing Activities | -431↓4.8% | -411↑5.2% | -434↓24.3% | -349↓45.2% | -240 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | 71↓81.2% | 378↑498.1% | -95↓629.9% | -13↓295.5% | -3 | |
| Cash at Beginning of Period | 427↑769.7% | 49↓65.9% | 144↓8.3% | 157↓2.1% | 160 | |
| Cash at End of Period | 497↑16.6% | 427↑769.7% | 49↓65.9% | 144↓8.3% | 157 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | 427↓47.9% | 821↑55.7% | 527↑29.0% | 409↑15.9% | 353 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.